Susan Hasty, Publisher
Table of Contents . . . September 18th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Law Weekly | Other Publications
Applied Imaging Corp. - Subsidiary formed to develop technology to detect circulating tumor cells
Ciphergen Biosystems, Inc - Promising results for detection of early stage ovarian cancer published
GMP Companies, Inc. - U.S. Patent Office issues two patents to pharmaceutical and diagnostics company
Medical Errors - Madisonville, Kentucky, hospital reviewing thousands of medical scans
Suros Surgical, Systems, Inc. - Company specializing in breast biopsy secures venture capital investment
Agennix, Inc. - Anticancer activity of natural immunomodulatory protein reported
Bioenvision, Inc. - Oncology company switches to NASDAQ stock market
Boston University - The C-terminus end of VEGF receptor-1 restrains angiogenic induction
Breast Cancer - Body size may affect risk of premenopausal breast cancer
Breast Cancer - Karen Neuburger offers sleepwear line to fund breast cancer research
Breast Cancer - Protective effects of exercise may result from reduced testosterone levels
Burnham Institute - Microarray-based MS-AFLP hybridization method devised
Cell Genesys, Inc. - Additional data from phase I trial of GVAX pancreatic cancer vaccine reported
ChromaVision Medical Systems, Inc. - Kenneth J. Bloom, MD, becomes medical director of cancer-diagnostics company
Cochin Institute, Paris - Leukocyte cell-derived chemotaxin 2 is central to liver cancer formation
Columbia University - Gene expression in biopsy specimens has prognostic value
Dana Farber Cancer Institute - CD8-deplted donor cell infusions effective for treatment of SCT relapse
Dana-Farber Cancer Institute - Cell-cycle triggers might be cancer drug targets
Dana-Farber Cancer Institute - Monoclonal antibody conjugate has potent antimyeloma activity
DiaSys Corp. - Company launches 10 new point-of-care rapid test products
Dongguk University - Hepatitis B virus X protein increases the invasive potential of liver cancer
Eli Lilly and Co. - FDA approves Alimta for second-line treatment of advanced lung cancer
Erimos Pharmaceuticals - Positive data presented from phase I trial of EM-1421 in refractory cancer
Genentech, Inc. - Researchers discover new tumor-fighting ability in Herceptin
Genentech, Inc. - Rituximab-mediated depletion of healthy B cells elucidated
Genetic Therapy, Inc. - Data describe selectivity, efficacy, lack of toxicity of oncolytic adenovirus
Genetronics Biomedical Corp. - Study supports electroporation-mediated DNA delivery without anesthesia
Genmab, A/S - HuMax-CD4 study in noncutaneous T-cell lymphoma launched
German Cancer Research Center - Familial risk for colorectal cancer mainly due to heredity, not environment
Hannover Medical School - Computer-aided navigation system aids pelvic tumor resection
Harvard University - Definitive hematopoiesis requires mixed-lineage leukemia gene
Harvard University - Early emergence of chromosomal instability likely in colorectal tumorigenesis
Harvard University - ErbB2 and TGF-beta cooperate to increase mammary tumor progression
Heraklion University Hospital - Pegulated liposomal doxorubicin improves chemoradiation efficacy
Houston VA Medical Center - Sprouty1 expression reduced in prostate tumor cells
INEA, Buenos Aires - EBV-1 is the most prevalent genotype of healthy carriers in Argentina
IRCCS, Neuromed - Suppressed Ras increases the sensitivity of glioma to cisplatin in vitro
Immunicon Corp. - Tumor-cell levels in blood predict success of treatment of advanced disease
Johns Hopkins University - PCR method detects promoter hypermethylation in multiple genes in breast cancer
Kansai Medical University - PIG7/LITAF mutations linked to EMPD pathogenesis
Key Laboratory of Biotherapy of Human Diseases - Recombinant xenogeneic endoglin boosts immune system response to tumors
Lorus Therapeutics Inc. - Biopharmaceutical company announces positive results in cancer management trial
Max Delbruck Center for Molecular Medicine - T cells with dual receptors suppress cancer growth
Mayo Clinic - High-dose therapy and autologous SCT for MM poorly responsive to initial therapy
Mayo Clinic - TIEG/Smad2/Bard1 expression has significant role in breast cancer proliferation
Meditech Research Limited - Phase IIb trial of HyCAMP to be initiated
Millennium Pharmaceuticals, Inc. - Velcade (bortezomib) for injection named Oncology Compound of the Year
Multiple Myeloma - Multiple Myeloma Research Consortium launches
Nagasaki University of Medicine - Pigment epithelium-derived factor gene therapy may treat liver cancer
National Cancer Center, Tokyo - MCC-465 shows promise for colorectal cancer treatment
National Cancer Institute - Asthma may increase non-Hodgkin lymphoma risk associated with pesticide exposure
National Oncology Institute, Italy - Progesterone modulation of MUC3 and MCA serum expression studied
National Taiwan University - Naked RNA vaccine controls tumors with down-regulated MHC expression
Natl. Cancer Institute, Italy - CYP1B1*3 polymorphism not associated with ovarian cancer in Caucasians
NewsAnalyzer - Major pharmaceutical deal for Rapinyl in North America announced
North American Scientific, Inc. - Elekta to add ultrasound targeting
Ohio State University - New compound could give some types of cancer the one-two punch
Oregon State University - Increased antioxidant level from apples is due to effects of fructose on urate
Orexo, AB - Endo licenses the rights to sublingual fentanyl product
Osaka University - Appropriate cell cycle control required for maintaining normal hematopoiesis
PEVIVA AB - Research tool quantifies epithelial cell death in cell culture supernatants
Paichai University, Taejon - Fruit extracts show antitumor activity in mice
Pharmacyclics, Inc. - Pharma company reports 2004 financial results, remains optimistic
Pro-Pharmaceuticals, Inc. - Pharmaceutical company granted patents for modified pectin material
Rockefeller University - New technique tracks migrating tumor cells
Scripps Research Institute - Expression pattern of v-Jun target genes characterized
Semiconductor Industry Association - Industry group seeks proposals for semiconductor workers cancer risk study
Spectrum Pharmaceuticals, Inc. - Oncology-focused drug company reports second quarter 2004 financial results
State University of Ghent Hospital - Follistatin counteracts the negative regulation of melanoma
Teikyo University, Tokyo - Distraction osteogenesis is effective for arthrodesis in infected prostheses
The Leukemia & Lymphoma Society - Team in Training recruits volunteers to train for fundraising for upcoming season
The Moyer Foundation - Seattle celebrities and businesses support Catch a Cure for Cancer weekend
Tobacco Use - Good understanding of ovarian cancer/smoking link prompts women to quit
Tokyo Medical and Dental University - Lip plumper prosthesis restores function after mandibulectomy
Tottori University - Researchers report on splenectomy in advanced proximal gastric cancer
U.S. Food & Drug Administration - Rac1 inhibits apoptosis in human lymphoma cells
U.S. National Cancer Institute - Novel imaging technique highlights lymph nodes
U.S. National Institutes of Health - Scientists establish database of genes associated with cancer drug resistance
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.